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BACKGROUND Although forward stroke volume (FSV) increases after
the successful MitraClip procedure for signiﬁcant mitral regurgitation
patients, the effect of FSV response on their outcomes remains un-
known. In this study, the prognostic impact of FSV response after the
MitraClip procedure was investigated.
METHODS Study population included 160 patients with the successful
MitraClip implantation whom FSV was able to be calculated using
pulse-wave Doppler at baseline and discharge in transthoracic echo-
cardiography. Responder of FSVwas deﬁned as an increase greater than
10% in baseline FSV at discharge. Clinical and echocardiographic out-
comes were compared between responders and nonresponders of FSV.
RESULTS There were 88 responders (42.6  9.7 ml to 59.3  13.5 ml,
p<0.001) and 72 nonresponders (54.0  11.3 ml to 49.2  11.3 ml,
p¼0.001) of FSV after the procedure. In both groups, left ventricular
(LV) end-diastolic volume was reduced and LV end-systolic volume
was not changed at discharge. Further reduction of LV end-diastolic
and end-systolic volumes was observed from discharge to 12-month
follow-up in responders (149.2  43.7 ml to 140.1  45.3 ml, p¼0.003;
80.8  38.3 ml to 75.1  40.9 ml, p¼0.01) but not in nonresponders
(152.8  56.2 ml to 154.1  58.1 ml, p>0.99; 89.9  51.2 ml to 88.4 
54.8 ml, p¼0.48). Although New York Heart Association functional
class improved in both groups, it was signiﬁcantly better in re-
sponders at 12-month (p¼0.048). Among patients with estimated
glomerular ﬁltration rate (eGFR) <60ml/min/1.73m2, signiﬁcant
improvement in eGFR was observed in responders (38.3  13.4 ml/
min/1.73m2 to 43.0  14.6 ml/min/1.73m2, p¼0.02) and not in non-
responders (38.2  13.3 ml/min/1.73m2 to 38.8  18.3 ml/min/1.73m2,
p¼0.76). The median follow-up duration with surviving patients was
1139 days (interquartile range 517 to 1813 days). All-cause mortality at
3-year was signiﬁcantly lower in responders (18.7%) than in non-
responders (39.0%, p¼0.009) (Figure). Multivariate analysis identiﬁed
nonresponders of FSV as an independent predictor of all-cause
mortality (hazard ratio 2.03, 95% conﬁdence intervals 1.05-3.95, p¼0.04).
CONCLUSIONS Responder of FSV after the MitraClip procedure was
associated with more favorable clinical outcomes. The FSV response
could predict the subsequent LV reverse remodeling.
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BACKGROUND Left atrial appendage occlusion (LAAO) may be
considered in patients with non-valvular atrial ﬁbrillation and
contraindication to oral anticoagulation therapy. We aimed to inves-
tigate the procedural safety and long-term outcome of patients un-
dergoing LAAO therapy due to previous intracranial bleeding (ICB).
METHODS Data from the Amplatzer Cardiac Plug multicenter registry
on 1047 consecutive patients were analyzed. Patients with previous
ICB as indication for LAAO were compared to patients with other
indications.
RESULTS A total of 198 patients (18.9%) with previous ICB were
identiﬁed. They were more commonly male (69.7 vs 60.1%, p¼0.012),
with history of previous stroke (63.6 vs 32.7%, p<0.001). The
CHA2DS2-VASc score was similar (4.51.5 vs 4.41.6, p¼0.687). The
HAS-BLED score was higher in patients with previous ICB (3.51.1 vs
3.11.2, p<0.001). The annual stroke risk was similar (5.72.8% vs
5.62.8%, p¼0.480) whereas the annual major bleeding risk was
higher for patients with previous ICB (6.43.9% vs 5.13.7%,
p<0.001). There was a trend towards less peri-procedural major safety
events for patients with previous ICB (2.5 vs 5.4%, p¼0.1). The average
follow-up was 1.3 years. The observed annual stroke/TIA rate (pro-
cedure and follow-up) for patients with previous ICB was 1.4% (4.3%
absolute reduction, 75% relative reduction according to the CHA2DS2-
VASc score) and 2.5% for the rest (3.1% absolute reduction, 55% rela-
tive reduction). The observed annual major bleeding rate (procedure
and follow-up) for patients with previous ICB was 0.7% (5.7% absolute
reduction, 89% relative reduction according to the HAS-BLED score)
and 2.4% for the rest (2.7% absolute reduction, 47% relative
reduction).
CONCLUSIONS Patients with previous ICB as an indication for LAAO
had a signiﬁcant reduction in stroke/TIA and a remarkably low fre-
quency of major bleeding during follow-up.
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BACKGROUND Cardiac computed tomography (CT) imaging of the
mitral annulus plays an integral role in appropriately sizing a trans-
catheter mitral valve implantation (TMVI) device. There are risks of
TMVI including paravalvular regurgitation and left ventricular
outﬂow tract (LVOT) obstruction. To mitigate these risks, measure-
ment of a D-shaped annulus has been proposed and has largely been
performed using cardiac CT. We sought to establish the accuracy of
